Literature DB >> 152621

Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.

N V Manyam, T A Hare, L Katz, B S Glaeser.   

Abstract

Gamma-aminobutyric acid (GABA) was measured by the ion-exchange fluorometric method in CSF from 22 individuals at risk for Huntington's disease (HD), six individuals with HD, and five neurologically normal controls. The mean (+/- SD) GABA level in the specimens from patients with HD was 142 +/- 27 pmoles/ml, whereas that of the normal control specimens was 297 +/- 87 pmoles/ml. The mean GABA level of the specimens from the individuals at risk for HD was 209 +/- 79 pmoles/ml; however, nine of these were in the normal range with a mean value of 281 +/- 72 pmoles/ml, while the other 13 were below the normal range with a mean value of 159 +/- 27 pmoles/ml. The data indicate that low GABA levels in CSF are evident prior to the onset of symptoms of HD but a predictive value can only be determined by continued observation of the clinical course of these at-risk individuals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 152621     DOI: 10.1001/archneur.1978.00500350032006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

Review 1.  Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.

Authors:  P J Schechter; A Sjoerdsma
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

2.  Sensitivity to ionising radiation of lymphocytes from Huntington's chorea patients compared to controls.

Authors:  D McGovern; T Webb
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

Review 3.  Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.

Authors:  T A Hare
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

4.  Huntington's disease - imbalance of free amino acids in the cerebrospinal fluid of patients and offspring at-risk.

Authors:  G Oepen; H Cramer; R Bernasconi; P Martin
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

5.  Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.

Authors:  H Kuroda; N Ogawa; Y Yamawaki; I Nukina; T Ofuji; M Yamamoto; S Otsuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

6.  Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.

Authors:  D Schmidt; W Löscher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

7.  Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.

Authors:  Natalia Szejko; Carmen Picón; Juan García-Caldentey; Justo Garcia de Yebenes; Jose Carlos Alvarez-Cermeño; Luisa Maria Villar; José Luis López-Sendón Moreno
Journal:  PLoS Curr       Date:  2018-08-31

Review 8.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.